human MIRN203 microRNA

01/01/2022 - "Our study suggests that NPWT promotes DFU healing by reducing the expression of hsa-miR-203 in peripheral blood and wound tissue. "
01/01/2022 - "Results showed that before NPWT, levels of hsa-miR-203 in peripheral plasma (P-miR-203) and wound margin tissue (T-miR-203) of DFU group were obviously increased compared to SUC group while expression of P-miR-203 decreased in NDFU group compared with NC group. "
01/01/2022 - "The changes of hsa-miR-203 in peripheral blood and wound tissue may be related to the therapeutic effect of NPWT."
01/01/2022 - "To investigate whether NPWT influences hsa-miR-203 levels in persons with DFU, we detected hsa-miR-203 levels in peripheral plasma and wound margin tissue from the following patients: type 2 diabetic (T2D) patients with DFU (DFU group), T2D patients without DFU (NDFU group), patients with chronic skin ulcer and normal glucose tolerance (SUC group), and healthy volunteers with normal glucose tolerance (NC group). "
01/01/2022 - "Downregulation of hsa-miR-203 in peripheral blood and wound margin tissue by negative pressure wound therapy contributes to wound healing of diabetic foot ulcers."

05/01/2013 - "The aim of this study was to investigate the effect of a eukaryotic expression vector expressing hsa-miR-203 on the sensitivity of K562 leukemia cells to arsenic trioxide (ATO) and the possible mechanism of action. "
05/01/2013 - "hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide."

12/01/2011 - "The frequent hsa-miR-203 methylation in lymphoid malignancies suggested a pathogenetic role of hsa-miR-203 methylation."
12/01/2011 - "hsa-miR-203 was more frequently hypermethylated in lymphoid than myeloid malignancies. "
12/01/2011 - "hsa-miR-203 was more frequently methylated in lymphoid than myeloid malignancies (P = 0.002). "
12/01/2011 - "Epigenetic inactivation of the hsa-miR-203 in haematological malignancies."
04/01/2016 - "The average relative expressions of hsa-miR-203 and hsa-miR-30c in tumor tissues were significantly different from those in adjacent normal tissues (P < 0.001), and the predictive power of the two hsa-miRNAs for PCa prognosis was reliable. "

04/01/2016 - "Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma."
04/01/2014 - "The two differentially expressed miRNA: hsa-miR-21 and hsa-miR-203 provide evidence for early diagnosis and treatment of esophageal carcinoma. "
02/01/2013 - "All three miRNAs showed significantly increased levels of methylation in cervical carcinomas, whereas methylation levels of hsa-miR-203 and -375 were also significantly increased in high-grade CIN. "

01/01/2018 - "No significant hsa-miR-203 expression was found in patients with hand fractures and intra-articular fractures after treatment for 7 days, which was remarkably upregulated on the 14th day. "
01/01/2018 - "Expression levels of hsa-miR-203 and PBOV1 in patients with hand fractures and intra-articular fractures after treatment were detected by quantitative Real-Time-Polymerase Chain Reaction (qRT-PCR). "